On 26 October, Kubota Pharmaceutical Holdings announced the issuance of its 41st and 42nd Stock Acquisition Rights. Each issue represents 20 million potential shares, with proceeds of approximately ¥1.201 billion and ¥1.200 billion, respectively, for a combined total of approximately ¥2.401 billion.
Kubota Pharmaceutical Holdings announced the issuance of Stock Acquisition Rights. The Stock Acquisition Rights to be issued this time will include an exercise price adjustment clause.
The 41st Stock Acquisition Rights represent 20 million potential shares and proceeds of approximately ¥1.201 billion. The 42nd Stock Acquisition Rights also represent 20 million potential shares, with proceeds of approximately ¥1.200 billion.
The news reports on the company's capital-raising efforts through the issuance of new shares, and the impact will be watched depending on developments going forward.